In March 2022, the transaction was successfully executed through a sale to Aceto, the provider of choice for differentiated specialty ingredients in the life sciences and advanced technology end markets. Aceto is a portfolio company of New Mountain Capital. "Through this process with G2 we've learned more about the inner workings of our own business than we imagined was left to learn. We leaned on their team for insight and advice and were introduced to a broad array of qualified parties. With the support of G2's team of seasoned experts we achieved an outcome that exceeded our expectations. Via G2 we have found in Aceto the right fit for ensuring continued success and a growth platform for our business, our customers, and our team," said Gameil Fouad, PhD, President, Biotron Laboratories, LLC. "The partnership between the Company and Aceto will continue to fuel the growth of its platform and allow for the expansion of their commercial reach on an accelerated timeline. We are thrilled to have led our client through a successful transaction and are excited to watch these two groups continue to flourish in this new partnership," said Victoria Arrigoni, Managing Director and Head of Industrials & Manufacturing at G2 Capital Advisors.